Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 2
2013 1
2015 1
2016 3
2018 1
2020 1
2022 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Dual Antiplatelet Therapy De-Escalation in Stabilized Myocardial Infarction With High Ischemic Risk: Post Hoc Analysis of the TALOS-AMI Randomized Clinical Trial.
Lee M, Byun S, Lim S, Choo EH, Lee KY, Moon D, Choi IJ, Hwang BH, Kim CJ, Park MW, Choi YS, Kim HY, Yoo KD, Jeon DS, Yim HW, Chang K; TALOS-AMI Investigators. Lee M, et al. JAMA Cardiol. 2024 Feb 1;9(2):125-133. doi: 10.1001/jamacardio.2023.4587. JAMA Cardiol. 2024. PMID: 38117483 Clinical Trial.
The impact of a dose of the angiotensin receptor blocker valsartan on post-myocardial infarction ventricular remodelling.
Park K, Kim YD, Kim KS, Lee SH, Park TH, Lee SG, Kim BS, Hur SH, Yang TH, Oh JH, Hong TJ, Park JS, Hwang JY, Jeong B, Bae WH; VALID Investigators. Park K, et al. Among authors: kim ks. ESC Heart Fail. 2018 Apr;5(2):354-363. doi: 10.1002/ehf2.12249. Epub 2018 Jan 17. ESC Heart Fail. 2018. PMID: 29341471 Free PMC article. Clinical Trial.
Pragmatic trial comparing routine versus no routine functional testing in high-risk patients who underwent percutaneous coronary intervention: Rationale and design of POST-PCI trial.
Yoon YH, Ahn JM, Kang DY, Park H, Cho SC, Lee PH, Hur SH, Kim WJ, Park CS, Lee BK, Suh JW, Yoon JH, Choi JW, Kim KS, Choi SW, Lee SN, Park SJ, Park DW. Yoon YH, et al. Among authors: kim ks. Am Heart J. 2020 Jun;224:156-165. doi: 10.1016/j.ahj.2020.03.019. Epub 2020 Mar 25. Am Heart J. 2020. PMID: 32402702 Clinical Trial.
Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
Hong BK, Park CG, Kim KS, Yoon MH, Yoon HJ, Yoon JH, Yang JY, Choi YJ, Cho SY. Hong BK, et al. Among authors: kim ks. Am J Cardiovasc Drugs. 2012 Jun 1;12(3):189-95. doi: 10.2165/11597410-000000000-00000. Am J Cardiovasc Drugs. 2012. PMID: 22462558 Clinical Trial.
A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension.
Lee HY, Kim YJ, Ahn T, Youn HJ, Chull Chae S, Seog Seo H, Kim KS, Rhee MY, Choi DJ, Kim JJ, Chun KJ, Yoo BS, Park JS, Oh SK, Kim DS, Kwan J, Ahn Y, Bae Park J, Jeong JO, Hyon MS, Cho EJ, Han KR, Kim DI, Joo SJ, Shin JH, Sung KC, Jeon ES. Lee HY, et al. Among authors: kim ks. Clin Ther. 2015 Nov 1;37(11):2581-2596.e3. doi: 10.1016/j.clinthera.2015.02.019. Epub 2015 Apr 4. Clin Ther. 2015. PMID: 25850881 Clinical Trial.
14 results